Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, et al.
Cochrane library (2021) Vol. 2021, Iss. 7
Open Access | Times Cited: 20

Showing 20 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 254
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Kelly Fogelson, Pieter C. Dorrestein, Amir Zarrinpar, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1069-1085
Open Access | Times Cited: 66
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 51
Diabetes and metabolic dysfunction-associated fatty liver disease
Timothy M. E. Davis
Metabolism (2021) Vol. 123, pp. 154868-154868
Closed Access | Times Cited: 45
Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Alejandra Mijangos-Trejo, Natalia Nuño‐Lámbarri, Varenka J. Barbero-Becerra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14918-14918
Open Access | Times Cited: 17
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach
Carmen Lara, Manuel Romero‐Gómez
European Cardiology Review (2024) Vol. 19
Open Access | Times Cited: 5
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, et al.
Cochrane library (2021) Vol. 2021, Iss. 6
Open Access | Times Cited: 38
Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
В. Т. Ивашкин, О. М. Драпкина, M. V. Maevskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2025) Vol. 35, Iss. 1, pp. 94-152
Open Access
Role of vitamin E in the treatment of non-alcoholic steatohepatitis
Yoshio Sumida, Masato Yoneda, Yuya Seko, et al.
Free Radical Biology and Medicine (2021) Vol. 177, pp. 391-403
Open Access | Times Cited: 27
Therapeutic Potential of Olive Leaf Extracts: A Comprehensive Review
Natália M. de Oliveira, Jorge Machado, Maria Helena Chéu, et al.
Applied Biosciences (2024) Vol. 3, Iss. 3, pp. 392-425
Open Access | Times Cited: 3
Vitamin E for people with non-alcoholic fatty liver disease
Hong-Zhu Wen, Hongyong Deng, Lili Yang, et al.
Cochrane library (2024) Vol. 2024, Iss. 10
Closed Access | Times Cited: 3
Updated Organic Composition and Potential Therapeutic Properties of Different Varieties of Olive Leaves from Olea europaea
Diana Melo, Natália M. de Oliveira, Maria Helena Chéu, et al.
Plants (2023) Vol. 12, Iss. 3, pp. 688-688
Open Access | Times Cited: 10
Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Leilei Wang, Pian-hong Zhang, Huihui Yan
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Is curcumin the new kid on the block for the treatment of MASH?
Shira Zelber‐Sagi, Jörn M. Schattenberg
Hepatology (2024)
Closed Access | Times Cited: 1
Efektivitas Pemberian Probiotik Dalam Memperbaiki Fungsi Hati pada Pasien Dengan Fatty Liver Non Alkoholik
Dyah Eka Andayani, Christina Mariani
Jurnal Sehat Indonesia (JUSINDO) (2024) Vol. 6, Iss. 01, pp. 349-412
Open Access
Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
Xiaoting Lu, Yong‐Dong Wang, Tingting Zhu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 2
Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease?
Ahmed M Baradeiya, Khaled M. Taghlabi, Abdelhalim N Saleh, et al.
Cureus (2023)
Open Access
The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease
T.-J. Chuang, Chung‐Wang Ko, Sz‐Iuan Shiu
Medicine (2023) Vol. 102, Iss. 40, pp. e35147-e35147
Open Access
Participation of lncRNAs in the development of diabetic complications: Systematic review and meta‐analysis. I. Rat
Leonardo‐Elías Cabrera‐Nájera, Gladys Chirino‐Galindo, Martín Palomar‐Morales
Diabetic Medicine (2023) Vol. 41, Iss. 2
Closed Access
For people with non-alcohol-related fatty liver disease (NAFLD), how do nutritional supplements compare?
Jane Burch, Sera Tort
Cochrane Clinical Answers (2021)
Closed Access
Page 1

Scroll to top